M&T Bank Corp Has $402,000 Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

M&T Bank Corp reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 9.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,678 shares of the company’s stock after selling 486 shares during the period. M&T Bank Corp’s holdings in Prestige Consumer Healthcare were worth $402,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC raised its holdings in Prestige Consumer Healthcare by 35.9% during the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company’s stock worth $162,000 after buying an additional 496 shares during the period. KBC Group NV increased its position in shares of Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company’s stock worth $189,000 after purchasing an additional 151 shares during the last quarter. QRG Capital Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 8.6% in the first quarter. QRG Capital Management Inc. now owns 5,971 shares of the company’s stock valued at $513,000 after buying an additional 475 shares during the last quarter. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $40,009,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Prestige Consumer Healthcare by 1,073.3% in the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock valued at $15,923,000 after buying an additional 186,524 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

PBH has been the topic of several research reports. Wall Street Zen raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a “hold” rating in a research report on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH stock opened at $75.08 on Thursday. The company has a 50 day simple moving average of $83.39 and a 200 day simple moving average of $82.29. The stock has a market cap of $3.71 billion, a price-to-earnings ratio of 17.50, a P/E/G ratio of 2.26 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 1 year low of $64.94 and a 1 year high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. Prestige Consumer Healthcare’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.02 earnings per share. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.